U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07135258) titled 'Atrial Fibrillation: In Search for the Optimal Target for Rate Control' on Aug. 13.

Brief Summary: A rate control strategy is commonly adopted in the management of patients with Atrial Fibrillation (AF). Controversies remain as regards to what constitutes the optimal target of rate control.

Current clinical guidelines recommend a resting target heart rate of 80 to 100-110 beats per min (bpm). Such recommendations were based largely on findings of the RACE II Trial, the only study of its kind, which demonstrated noninferiority of the lenient versus a strict rate control approach. Despite merits of the study, interpretation of RACE I...